Mkt Cap$2.26T-0.77%
24h Vol$46.05B
BTC Dom56.5%
ETH Dom8.9%
F&G18Extreme Fear
BTC$63,742.00-0.63% ETH$1,662.41-0.87% USDT$0.9994-0.01% BNB$603.87-0.64% USDC$0.9998+0.00% XRP$1.13-1.13% SOL$67.43-0.95% TRX$0.3188+0.47% FIGR_HELOC$1.02-1.41% HYPE$60.33+0.91% DOGE$0.0863-1.49% USDS$0.9997-0.01% LEO$9.72+0.83% RAIN$0.013+0.39% ZEC$424.29+2.30% XMR$341.04-1.04% BTC$63,742.00-0.63% ETH$1,662.41-0.87% USDT$0.9994-0.01% BNB$603.87-0.64% USDC$0.9998+0.00% XRP$1.13-1.13% SOL$67.43-0.95% TRX$0.3188+0.47% FIGR_HELOC$1.02-1.41% HYPE$60.33+0.91% DOGE$0.0863-1.49% USDS$0.9997-0.01% LEO$9.72+0.83% RAIN$0.013+0.39% ZEC$424.29+2.30% XMR$341.04-1.04%
News

ANRO

Total Stories
1
Section
ANRO
Why Did ANRO Stock Jump in Premarket: FDA Fast Track Schizophrenia Drug
Market Analysis

Why Did ANRO Stock Jump in Premarket: FDA Fast Track Schizophrenia Drug

ANRO stock rose over 6% in premarket after the FDA granted Fast Track status to ALTO-101, its schizophrenia drug candidate.

Tim FriesOct 3, 20253 min read